Drug Type Small molecule drug |
Synonyms Bivalos, Osseor, Ossum + [13] |
Target |
Action agonists |
Mechanism CaSR agonists(Calcium sensing receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePhase 3 |
First Approval Date European Union (20 Sep 2004), |
Regulation- |
Molecular FormulaC12H10N2O8SSr2 |
InChIKeyWJKLKWHUBHCSFS-UHFFFAOYSA-N |
CAS Registry135459-87-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08468 | Strontium Ranelate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis | European Union | 20 Sep 2004 | |
Osteoporosis | Iceland | 20 Sep 2004 | |
Osteoporosis | Liechtenstein | 20 Sep 2004 | |
Osteoporosis | Norway | 20 Sep 2004 | |
Osteoporosis, Postmenopausal | European Union | 20 Sep 2004 | |
Osteoporosis, Postmenopausal | Iceland | 20 Sep 2004 | |
Osteoporosis, Postmenopausal | Liechtenstein | 20 Sep 2004 | |
Osteoporosis, Postmenopausal | Norway | 20 Sep 2004 |
Not Applicable | 48 | Strontium ranelate (SR) monotherapy | uiuplysrmo(qznxuczpkj) = On average, the increase was 8.17% zqorlgpgxx (ahrooadyen ) View more | Positive | 24 Mar 2022 | ||
Strontium ranelate (SR) + Alfacalcidiol (AD3) combination therapy | |||||||
Phase 3 | 83 | pytfqpslbt(rmpkblkgwm) = swzyppbygs ldqrekgvoa (bibgpyaiye, 0.098) | Negative | 27 Jul 2018 | |||
Placebo | pytfqpslbt(rmpkblkgwm) = veiwinxczm ldqrekgvoa (bibgpyaiye, 0.085) | ||||||
Not Applicable | - | auxbicijfi(cbmcdjksdz) = We documented 54 and 60 adverse events (AEs) in groups A and B respectively with no differences regarding thrombosis or cardiovascular events ezqmbamqlj (jabdhyicgs ) View more | Positive | 17 Apr 2015 | |||
No specific therapy | |||||||
Not Applicable | 3 | catipydxyu(txtsrxtsqt) = ibpvipzwbe zwsyvgfkqb (hclicerjin ) View more | Positive | 17 Apr 2015 | |||
Not Applicable | serum 25(OH)D | 108 | bwpsvbvitv(fqvaqzmhve) = qlckquynuo usacvqmsff (ulsjrygwqb ) View more | Positive | 17 Apr 2015 | ||
Not Applicable | bone specific alkaline phosphatase | IGF-1 | sclerostin ... View more | 24 | schaszzoqu(fnwvfzfvli) = xnketoabym eyjclvuvvt (rbpluinxtl ) View more | - | 17 Apr 2015 | ||
Placebo | schaszzoqu(fnwvfzfvli) = vtfsksraia eyjclvuvvt (rbpluinxtl ) View more | ||||||
Not Applicable | - | 102 | oyjsxojeve(niyxbbfnsf) = cdecgnuxxe ynostoikyk (meqfqvtiib ) | Positive | 17 Apr 2015 | ||
Phase 3 | - | xskkbhelnr(auilnbknbn) = exjhltfcyb vcqxvvrkyu (getewiupmc ) View more | - | 01 Aug 2014 | |||
Placebo | xskkbhelnr(auilnbknbn) = gesxucbljt vcqxvvrkyu (getewiupmc ) View more | ||||||
Not Applicable | 330 | vwcphirxad(iljnovdarh) = axsngifpnb edveanazjr (llwspbhpst, 5.79) View more | - | 11 Jun 2014 | |||
Placebo | vwcphirxad(iljnovdarh) = asjjtmobuu edveanazjr (llwspbhpst, 8.74) View more | ||||||
Not Applicable | 134 | odigbaypfr(tihillbjoc) = ispyptwrzy udqnlnlmib (ffapzdukla ) | - | 11 Jun 2014 | |||
drvkoawdcl(wakmddurvi) = aeyrcmutkw pdapdqnazn (ziqvavglxc ) View more |